Getting at the Variable Expressivity of Von Willebrand Disease
暂无分享,去创建一个
[1] F. Rosendaal. High Levels of Factor VIII and Venous Thrombosis , 2000, Thrombosis and Haemostasis.
[2] J. Sixma,et al. The Half-life of Infused Factor VIII Is Shorter in Hemophiliac Patients with Blood Group 0 than in those with Blood Group A , 2000, Thrombosis and Haemostasis.
[3] P. Reitsma,et al. High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.
[4] P. Mannucci,et al. Low Platelet 2β1 Levels in Type I von Willebrand Disease Correlate With Impaired Platelet Function in a High Shear Stress System , 1999 .
[5] P. Leder,et al. A normal beta-globin allele as a modifier gene ameliorating the severity of alpha-thalassemia in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] K. Mohlke,et al. Mvwf, a Dominant Modifier of Murine von Willebrand Factor, Results from Altered Lineage-Specific Expression of a Glycosyltransferase , 1999, Cell.
[7] R. Cummings,et al. Structures Common to Different Types of Glycans , 1999 .
[8] R. Hynes,et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Bertina,et al. Characterization of the Genetic Defects in Recessive Type 1 and Type 3 von Willebrand Disease Patients of Italian Origin , 1998, Thrombosis and Haemostasis.
[10] H. Whittle,et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.
[11] F. Rosendaal. Risk factors for venous thrombosis: prevalence, risk, and interaction. , 1997, Seminars in hematology.
[12] D. Ginsburg,et al. Von Willebrand disease. , 2008, Pediatric clinics of North America.
[13] K. Cooney,et al. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Mohlke,et al. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing , 1996, British journal of haematology.
[15] P. Reitsma,et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. , 1996, Blood.
[16] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[17] Y. Natori,et al. Detection of N‐acetylgalactosaminyltransferase mRNA which determines expression of Sda blood group carbohydrate structure in human gastrointestinal mucosa and cancer , 1996, International journal of cancer.
[18] R. Kaufman,et al. Moderation of hemophilia A phenotype by the factor V R506Q mutation. , 1996, Blood.
[19] P. Mannucci,et al. Low Prevalence of the Factor V Leiden Mutation Among “Severe” Hemophiliacs with a “Milder” Bleeding Diathesis , 1995, Thrombosis and Haemostasis.
[20] K. Cooney,et al. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. , 1995, Blood.
[21] J. Lowe,et al. Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen. , 1994, The Journal of biological chemistry.
[22] E. Lander,et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.
[23] D. Malo,et al. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.
[24] P. Reitsma,et al. Recessive inheritance of von Willebrand's disease type I , 1993, The Lancet.
[25] M. Blombäck,et al. A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients. , 1992, Human molecular genetics.
[26] D. Triplett. Laboratory diagnosis of von Willebrand's disease. , 1991, Mayo Clinic proceedings.
[27] R. Cody,et al. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Sweeney,et al. The RIIIS/J inbred mouse strain as a model for von Willebrand disease. , 1990, Blood.
[29] H. Reisner,et al. Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor. , 1989, Blood.
[30] H. Nagura,et al. DDAVP and epinephrine-induced changes in the localization of von Willebrand factor antigen in endothelial cells of human oral mucosa. , 1988, Blood.
[31] W. Marks,et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.
[32] F Rodeghiero,et al. Epidemiological investigation of the prevalence of von Willebrand's disease. , 1987, Blood.
[33] P. Magnus,et al. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. , 1985, American journal of human genetics.
[34] P. McKee,et al. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. , 1979, Journal of Biological Chemistry.
[35] R. Elston,et al. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. , 1979, Blood.
[36] L. Hoyer,et al. The effects of epinephrine infusion in patients with von Willebrand's disease. , 1976, The Journal of clinical investigation.
[37] W. Altemeier,et al. Natural Resistance to Infection. , 1961, Progress in surgery.